CryoPort Inc. (CYRX) Dividend Safety Gauge & 10-Year DRIP Compounder

Per the Roarable RQD rating, CYRX scores 43 out of 100, with a letter grade of D- and a verdict label of "Roarable Sell — Vulnerable Balance Sheet & Flow." The five pillars are:

• Fundamental Cash Engine: 1 / 20. Per the RQD rating, this is driven by ROIC of -11.5% and an FCF yield of -2.7%. This is the weakest pillar and signals that the business is not currently converting capital into positive economic returns or free cash flow. For a prospective investor, the cash engine is the core question, and today it is not supporting the valuation on a cash basis.
• Whale 13F Flow: 17 / 20. Per the RQD rating, this reflects institutional accumulation and options positioning. This is the strongest pillar and indicates that large holders are positioned constructively. The data does not itemize the holders, so the composition and size of positions cannot be verified from the source data.
• Insider Conviction: 7 / 20. Per the RQD rating, this reflects SEC Form 4 and Congressional PTR cluster flow. The weak score is consistent with the Moomoo headline in the news section referencing insider selling of US$3.4m.
• Macro Regime Fit: 8 / 20. Per the RQD rating, beta is 1.0 with sector sensitivity noted. A beta of 1.0 means the stock is expected to move roughly in line with the market, which provides neither a defensive buffer nor a high-beta amplification.
• Forensic Balance Sheet: 10 / 20. Per the RQD rating, the Altman Z-Score is 1.33, the Piotroski F-Score is 5/9, and Debt/Equity is 0.5. An Altman Z in this range is a stress signal in the source framework, so the balance sheet is a meaningful drag on the score.

Taken together, the RQD profile describes a stock with strong institutional support and a weak underlying cash and balance-sheet foundation. Upside drivers would need to come from improving operating economics, since the rating shows the fundamental engine is the largest deficit. The valuation tradeoff is that the market data shows a P/E (TTM) of 11.8 and a forward P/E of 9.9 against a negative operating margin, which means the earnings multiple is not reflecting the operating loss in a straightforward way and should be interpreted cautiously.

Per the SEC financials, revenue moved from $168.7M in FY 2023 to $156.8M in FY 2024 and $176.2M in FY 2025, while operating income remained negative in all three periods. FY 2025 net income of $78.3M is positive despite a negative operating income of $-36.8M, a divergence the source data does not explain. The market data reports an operating margin of -20.9%, a gross margin of 47.1%, and a net margin of 44.4%. Per the Roarable RQD rating, ROIC is -11.5%, the Altman Z-Score is 1.33, and the Piotroski F-Score is 5/9. The reported cash balance rose to $250.5M in FY 2025 from $34.1M in FY 2024, while debt is Not available in source data for all periods, so the balance sheet posture cannot be fully characterized.

Per the recent news feed, the most prominent catalyst is a headline stating that BTIG raised its price target to $26 on facility expansion, flagged as a GREEN catalyst by Investing.com. Other items include a Moomoo report of US$3.4m in insider share sales, flagged YELLOW as a risk watch item for signaling hesitancy. MarketBeat reports the share price crossing above the 200-day moving average and reaching a new 52-week high, both flagged YELLOW as market-wire items. A Benzinga transcript covers the Q2 2026 earnings call, and a Simply Wall St piece references an 86% rally, flagged GREEN. The Butterfly Supply-Chain Graph reports no supply-chain links and no proprietary signals, so no butterfly-derived catalysts are available.

• What drove the divergence between FY 2025 net income of $78.3M and operating loss of $-36.8M, and is the net income figure driven by non-operating or one-time items?
• What is the debt level and debt structure in each period, given that debt is reported as N/A across the SEC financials?
• What are the company's product lines, customer concentration, and revenue mix, which the profile and financials do not describe?
• What is the composition and size of the institutional and options positioning behind the 17/20 whale-flow pillar, and do the holder positions persist?
• What is the status and expected timing of the facility expansion cited in the BTIG headline, and what capital is required to fund it against a $250.5M cash balance?